In essential hypertension, increased renal resistive index (RRI) is associated to a reduction of renal function and microalbuminuria, and to renal tubulo-interstitial damage. A tubulo-interstitial inflammatory infiltration was found in experimental models of hypertension, and serum high-sensitive C-reactive protein (hsCRP) levels correlated with urinary markers of tubulointerstitial damage in humans. We studied the relationship between RRI and serum hsCRP in hypertensives with preserved renal function, without microalbuminuria. We investigated hypertensive patients without diabetes, renal failure, microalbuminuria or major inflammatory disease. Serum levels of hsCRP were assayed. RRI was calculated by intrarenal Doppler ultrasound and considered pathologic when X0.70 or 495% of upper confidence limit expected for age decade. The renal volume-to-resistive index ratio (RV/RRI) was also calculated. We evaluated 85 patients (57 ± 14 years, 61 males). Patients with pathologic RRI (n ¼ 21) were older and had significantly higher hsCRP levels (4.70 ± 2.30 vs 2.93 ± 2.09 mg l À1 , Po0.01) compared with patients with normal RRI, as well as patients with decreased RV/RRI (n ¼ 43). HsCRP was directly related with RRI (r ¼ 0.41, Po0.001) and inversely with RV/RRI (r ¼ À0.35, Po0.001). HsCRP proved to be a significant predictor of both pathologic RRI and decreased RV/RRI, even after adjustment. In essential hypertension low-grade inflammation is associated with tubulo-interstitial damage evaluated by Doppler ultrasonography.
Introduction
Chronic low-grade inflammation has been implicated in hypertension, both as a primary and a secondary event.
1,2 Increase in serum high-sensitive C-reactive protein (hsCRP) levels were associated with hypertensive damage in different vascular beds, including kidney. 3 Increased urinary albumin excretion (UAE), namely either micro-or macroalbuminuria, is a well-established marker of hypertensive renal target-organ damage (TOD), mainly characterized by glomerular vasculature involvement. 4 An increase in both hsCRP and UAE occurs in a large proportion of nondiabetic essential hypertensive patients, 5 and a strict direct association between high hsCRP levels and increased UAE were found. 6, 7 The ultrasound measurement of the renal resistive index (RRI) has been proposed in adjunct to UAE to assess the severity of renal TOD in hypertension. 8, 9 The increase in RRI values is associated with the presence and extent of tubulo-interstitial damage in renal parenchymal disease, 10 and specifically in hypertensives with 11 or without glomerular damage. 12 The existence of tubulo-interstitial inflammatory infiltration is a common feature of experimental models of hypertension. 13, 14 Moreover, in hypertensive patients with type 2 diabetes the urinary excretion of N-acetyl-b-glucosaminidase, marker of tubulo-interstitial damage, was correlated with hsCRP serum levels. 15 To date, a single recent study reported a direct correlation between RRI and hsCRP in untreated hypertensive patients. 16 Nevertheless, the occurrence of a relationship between tubulo-interstitial damage evaluated by intrarenal Doppler ultrasound and low-grade inflammation in essential hypertension remains controversial.
We reported the preliminary results of a study that was aimed to evaluate the relationship between hsCRP, RRI and renal volume-to-resistive index ratio (RV/RRI), markers of tubulo-interstitial damage and intrarenal arteriolopathy, 17 in patients with WHO (World Health Organization) stage I-II essential hypertension, in chronic antihypertensive treatment, with preserved renal function and normal UAE.
Patients and methods
The study was an observational, cross-sectional study carried out on subjects in an age group between 35 and 80 years with WHO stage I-II essential hypertension, who attended our outpatients' clinic from January to December 2010. All patients were taking antihypertensive drugs. Specifically, the duration of antihypertensive therapy coincided with the duration of hypertension, that is, patients had been on treatment for at least 6 months.
According to the presence of intrarenal abnormalities, that is, pathologic RRI and/or decreased RV/RRI, patients were divided in normal or pathologic RRI groups, and in normal or decreased RV/RRI groups.
Diagnosis of essential hypertension was previously made after a complete medical history, physical examination and routine biochemical analyses of blood and urine.
All patients underwent the following procedures: (1) office blood pressure (BP) measurement; (2) blood and urine sampling; (3) evaluation of renal ultrasound and Doppler studies; (4) evaluation of hypertension-related organ damage (TOD), including urinary albumin excretion (UAE), echocardiogram and carotid ultrasonography.
On the day of study, height, weight and waist circumference were measured and venous blood was drawn. Body mass index (BMI) was defined as the weight (kg) divided by the square of the height (m 2 ), and waist circumference was measured at the midpoint between the lower rib margin and the iliac crest to the nearest 0.5 cm.
BP was measured using a mercury sphygmomanometer. Measurements started after the subjects had comfortably rested for 5 min in the sitting position. Three measurements were taken at 1-min intervals, and the average was used to define clinic systolic BP (SBP) and diastolic BP (DBP). Pulse pressure (PP) was calculated as, PP ¼ SBP-DBP.
Blood samples were drawn after overnight fasting and 15 min of supine rest by venipuncture to determine fasting-blood glucose, creatinine levels, blood urea nitrogen, electrolytes, triglycerides, total and HDL-cholesterol and other standard biochemical evaluations according to routine methods.
Creatinine clearance was estimated by the Cockroft-Gault formula. LDL-cholesterol was calculated using Friedewald's formula.
Two 24-h urine collections were obtained from each patient to evaluate UAE. The average of the two UAE values was used for the analyses.
Metabolic syndrome (MS) was defined according to Adult Treatment Panel III criteria, modified as recommended in the latest American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
Smoking was defined as current smoking or having a history of habitual smoking.
Exclusion criteria were secondary forms of arterial hypertension, (SBP) of 220 mm Hg or higher, ischemic heart disease/acute coronary syndrome or stroke in the previous 6 months, left-ventricular ejection fraction o50%, impaired glucose tolerance or diabetes mellitus, renal failure (creatinine clearance o60 ml min À1 ), micro/macroalbuminuria, erythrocyturia (erytrocytes 420 ml
À1
) and/or leukocyturia (leukocites 418 ml
), presence of a major illness, such as cancer, liver disease, chronic and acute inflammatory disease or infectious disease in the previous 3 months. No subjects were in treatment with antiinflammatory drugs.
All patients gave informed consent and the procedures followed were in accordance with the principles of the Declaration of Helsinki.
Renal ultrasonography
Renal volume (RV) was measured by use of the ellipsoid formula (volume ¼ length Â width Â thickness Â p/6). The mean of the two kidney volumes for each patient was taken into consideration and corrected for BMI. 18 For RRI measurement, peak systolic and end-diastolic velocity were measured on the blood-flow velocity waveform obtained by placing the sample volume of the Doppler beam on interlobar arteries, visualized by color in three different positions (superior, mid and inferior) in each of the two kidneys. The mean RRI was calculated according to the following formula: (peak systolic velocity-end-diastolic velocity)/peak systolic velocity. Each sonographic parameter was measured by the same examiner to avoid interobserver variability. Intraobserver variation of RRI measurements was 0.08 (ref.19) . All RRI X0.70 were considered pathologic. For values o0.70, RRI were considered pathologic when they exceeded the 95% upper confidence limit expected for the age decade, as previously described. 19 Decreased renal volume-to-resistive index ratio (RV/RRI) was defined for values below the median,that is o176 ml Â m À2 kg À1 .
Urinary albumin concentrations
Urinary albumin concentrations were measured by an immunonephelometric technique with a limit detection of 0.4 mg dl À1 and an interassay variation of 3.5%. The results were expressed as mg per 24 h.
Cardiac ultrasonography
Echocardiographic studies were performed by an experienced senior cardiosonographer using a Vivid 7 ultrasound machine (Horten, Norway) with a 2, 5-3 and 5-MHz convex array probe, according to the guidelines of the American Society of Echocardiography. Left ventricular mass index (LVMI) was calculated as LV (left ventricular) mass divided by body surface area. LV hypertrophy (LVH) was defined as LVMI X125 g m À2 for men and X110 g m À2 for women.
Carotid ultrasonography
Patients were evaluated using a Toshiba SSA-270 ultrasound machine (Otawara-Shi, Tochigi, Japan) and a 7,5-MHz transducer. The IMT of both carotid arteries was evaluated as previously described. 20 The IMT was always measured on the common carotid artery outside the plaque, if any were present. Each measurement was calculated by taking the average of three readings. Carotid artery thickening was defined as an average IMT X0.9 mm. All examinations were performed by a single experienced examiner who was blinded to the clinical and biochemical data.
Statistical analysis
Data was reported as frequencies (percentage) and means ± s.d., except for variables not normally distributed, that is, UAE, IMT, triglycerides and HDL cholesterol, expressed as median (range).
Logarithmically transformed values of variables not normally distributed were used for the statistical analysis. Means were compared by the two-tailed Student's t-test for independent samples. Comparisons of proportion among groups were performed using the Fisher's exact test.
To study the relationships between RRI, RV/RRI and other variables, Pearson's correlation test was used. To assess the independent contribution of hsCRP to RRI and RV/RRI, hsCRP and the variables that were significantly correlated with RRI and/or with RV/RRI, that is, age, logUAE, creatinine clearance, LVMI, PP and logIMT, were entered as covariates in a multivariable linear regression model (dependent variables: RRI and RV/RRI).
To assess the independent predictive value of hsCRP to pathologic RRI, we entered hsCRP with the variables that were significant crude predictors in the univariate logistic regression analyses, that is, age, logUAE, PP, presence of MS and diuretic therapy, as covariates in a series of bivariate logistic regression analyses (outcome: pathologic RRI). To assess the independent predictive value of hsCRP to decreased RV/RRI, we entered hsCRP with the variables that showed the highest statistical power at the univariate logistic regression analyses, that is, age, male gender and presence of MS, as covariates in the multivariable logistic regression analysis (outcome: decreased RV/RRI).
Probability values of Po0.05 were considered significant. All statistical analyses were performed using statistical software (SPSS, version 17.0 for Windows; SPSS Inc., Chicago, IL, USA).
Results
The stratification of study population based on RRI and RV/RRI values yielded a group of 64 patients with normal RRI (0.62 ± 0.04) and 21 patients with pathologic RRI (0.72 ± 0.03, Po0.01), and 42 patients with normal RV/RRI (201 ± 17 ml Â m À2 kg
À1
) and 43 patients with decreased RV/RRI (156 ± 16 ml Â m À2 kg À1 , Po0.01). Demographic and clinical characteristics are shown in Table 1 . Patients with pathologic RRI and/or decreased RV/RRI were older and had higher PP, compared with those with normal RRI and/or RV/RRI. Patients with pathologic RRI and patients with decreased RV/RRI showed a slightly higher degree of UAE, compared with patients with normal RRI and RV/RRI values. Moreover, a higher prevalence of MS was observed in patients with pathologic RRI, compared with patients with normal RRI, and in patients with decreased RV/RRI, compared with patients with normal RV/RRI. There were no significant differences in total cholesterol, HDL cholesterol, triglycerides and smoking habit. IMT, LVMI and prevalence of LVH did not significantly differ between groups. Of note, there was a high prevalence of male gender among patients with normal RV/RRI.
Patients with pathologic RRI showed significantly increased hsCRP values, as well as those with decreased RV/RRI (Figure 1) .
A tight positive correlation was found between RRI and age (r ¼ 0.51, Po0.001), and between RRI and hsCRP (r ¼ 0.41, Po0.001, Figure 2a At the multivariable linear regression analysis, a significant correlation persisted between hsCRP and RRI (b ¼ 0.24, Po0.05), and between hsCRP and RV/ RRI (b ¼ À0.24, Po0.05), even after adjustment for the other variables (Table 2) .
Univariate logistic regression analyses reported hsCRP, age, PP, UAE, presence of MS and diuretic therapy as significant unadjusted predictors of both pathologic RRI and decreased RV/RRI (Table 3) . Creatinine clearance and male gender proved to be inverse unadjusted predictors of decreased RV/RRI (Table 3) .
Serum level of hsCRP remained a significant predictor of both pathologic RRI and decreased RV/RRI even after adjustment, respectively for UAE, PP, presence of MS, age, and diuretic therapy (bivariate analyses, Table 4 ) and for age, presence of MS and male gender (multivariable analysis, Table 4 ). In fact, each 1 mg l À1 increase in hsCRP was
Renal resistive index and low-grade inflammationshown to entail B30-40% increased probability to the presence of pathologic RRI and/or decreased RV/RRI.
Discussion
The present study shows an independent association between a marker of low-grade inflammation, that is serum hsCRP levels and early renal hypertensive tubulo-interstitial damage evaluated by RRI and RV/RRI in essential hypertensives undergoing chronic antihypertensive treatment, with normal renal function and without microalbuminuria. These findings strengthen the intricate link between inflammation and hypertensive renal TOD, till now mainly supported by the relationship between serum hsCRP and UAE/MA. 6, 7 In literature, increased RRI is demonstrated to associate with early signs of renal and extra-renal TOD in essential hypertension. 8, 21 Specifically, patients with processes predominantly of the tubulo-interstitial compartment tend to have higher RRI than patients with glomerular-based processes. [22] [23] [24] Accordingly, high RRI values detected the early involvement of renal interstitium in hyperuricemic patients with normal creatinine clearance and absence of MA, as confirmed by perfusion renal scintigraphy. 12 In addition, the ratio between renal volume and RRI (RV/RRI) was proposed as an integrated indicator of intrarenal arteriolopathy, as a reduction of RV and an increase in RRI occur in hypertensives as preclinical chronic ischemia ensues. 17 In our study, the association between hsCRP, RRI and RV/RRI in hypertensive patients with normal renal function and without MA, that is, without glomerular damage, is in line with the hypothesis of an early inflammatory involvement of renal interstitium in essential hypertension. In fact, tubules and interstitium, rather than glomerular capillaries, are considered to constitute the initial site of kidney injury, 25 and a common feature of experimental models of salt-sensitive hypertension is the existence of tubulo-interstitial inflammatory infiltration, in addition to intrarenal arteriolopathy. 13 In particular, the experiment by Murphy et al. 26 showed 21 (33) 8 (38) 13 (31) 16 (37) Ca-channel blockers (n (%)) 6 (9) 3 (14) 4 (10) 5 (12) Diuretics (n (%))
16 (25) 13 (62)** 9 (21) 20 (47)* Statins (n (%))
18 (28) 6 (29) 14 (33) 10 (23) Abbreviations: ACEis, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; IMT, intima-media thickness; LVH, left ventricular hypertrophy; LVMI, left ventricular mass index; MAP, mean arterial pressure; MS, metabolic syndrome; PP, pulse pressure; RRI, renal resistive index; RV, renal value; UAE, urinary albumin excretion. Data are reported as mean ± s.d. or percentage, except for UAE, IMT, triglycerides and HDL-cholesterol, which are expressed as median (range). *Po0.05; **Po0.01.
that an increase in renal pelvic and interstitial pressure decreased arterial distensibility and increased RRI values in isolated rabbit kidneys. On the other hand, the relationship between RRI and hsCRP shown in our patients could be rather a secondary effect of increased systemic arterial stiffness and/or atherosclerosis that occurs in hypertensives, possibly affecting both hsCRP and RRI. In fact, elevations in hsCRP have been associated with reduced arterial elasticity 27 and increased arterial stiffness measured by pulse wave velocity (PWV), 28, 29 and the relationship between hsCRP and IMT as an early marker of atherosclerosis was shown. 30, 31 Moreover, a strict dependence of RRI from arterial stiffness was demonstrated in experimental studies, 8, 26 and an association was confirmed between RRI and PP, 21, [32] [33] [34] [35] and between RRI and PWV. 33, 36 A relationship between RRI and IMT was also reported. 8, 21, 34, 35 In our study, the correlation between RRI, RV/RRI and hsCRP persisted even after adjustment for age, IMT and PP, which are all related to systemic atherosclerosis and arterial stiffness. The high RRI and low RV/RRI values observed in our patients could mainly detect intrarenal tubulo-interstitial and arteriolar inflammatory damage associated with systemic low-grade inflammation, whilst 'extrarenal' RRI and RV/RRI determinants seem to have a minor role. CRP could be directly involved in local renal inflammatory pathways activated in hypertension, in particular at the tubulo-interstitial compartment level. CRP is expressed by renal tubular cells after stimulation with IL-6 in vivo, 37 and the experimental study by Parra et al. 38 hypothesizes that an autoimmunity to stress proteins is involved in the persisting low-grade inflammatory infiltrate in the tubulo-interstitial areas of the hypertensive kidney.
Finally, the presence of MS also proved to be a strong unadjusted predictor for both pathologic RRI and decreased RV/RRI, (Table 3) . However, the adjustment for the presence of MS did not significantly affect the relation between hsCRP and Renal resistive index and low-grade inflammation A Berni et al intrarenal abnormalities at the bivariate (data not shown) and multivariable logistic regression analysis (Table 4 ). This finding allows to rule out a confounding effect of MS on hsCRP and RRI relationship found in our patients, all hypertensives and not affected by diabetes mellitus. Indeed, patients with MS and diabetes mellitus have higher hsCRP values than patient with MS and without diabetes mellitus.
39
Limitations First, we included a small number of subjects, which is the main limitation of our study. However, on the other hand, usage of strict selection criteria (absence of diabetes, renal failure, microalbuminuria and inflammatory disease or infectious disease, etc.) made the finding of the significant relationship between RRI, RV/RRI and hsCRP more relevant and straight. Second, all patients were taking antihypertensive drugs and prevalence of diuretic therapy was more in pathologic RRI and decreased RV/RRI groups. However, the different prevalence of diuretic therapy did not affect the relationship between hsCRP, RRI and RV/RRI. Third, we performed neither the assessment of direct measure of arterial stiffness, that is, PWV, which could define more precisely the RRI variations depending on systemic arterial stiffness, nor the evaluation of markers of tubulo-interstitial damage, such as urinary excretion of N-acetyl-bglucosaminidase, which could focalize the compartment of renal damage. Finally, in our study, the tubulo-interstitial compartment was indirectly investigated by RRI measurement, as the biopsy assay of renal tissue was beyond the aim of the study and not ethically acceptable. However, owing to the observational design, the aim of the present study is not to draw definitive conclusions, but to pilot further and specifically addressed and larger studies.
Conclusions
The associations between intrarenal Doppler ultrasound measurements and low-grade inflammation in hypertensive patients without glomerular damage may provide a new insight into the pathophysiological mechanisms of early renal tubulo-interstitial hypertensive damage, a point to which our preliminary data can answer only in inferential terms. The early detection of renal tubulo-interstitial damage in hypertensive patients without glomerular damage but with low-grade inflammation could select a subpopulation of patients at high risk for renal damage progression. Longitudinal prospective studies are needed to evaluate the predictive role of RRI and RV/RRI in hypertensive patients, and, if our findings were to be confirmed, new opportunities for the improvement of renal damage prevention could be opened.
